MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sumitomo Dainippon Pharma Co., Ltd. (“Sumitomo Dainippon Pharma”) and its U.S. subsidiary, Sunovion Pharmaceuticals Inc. (“Sunovion”), jointly filed patent infringement lawsuits on January 14, 2015 in the U.S. District Court for the District of New Jersey against Emcure Pharmaceuticals Limited, Emcure Pharmaceuticals USA, Inc., and InvaGen Pharmaceuticals Inc. regarding their submissions of Abbreviated New Drug Applications (“ANDAs”) for generic copies of Latuda® (lurasidone HCl) tablets. The lawsuits allege infringement of Sumitomo Dainippon Pharma’s U.S. Patent No. 5,532,372 (“the ’372 Patent”).
Help employers find you! Check out all the jobs and post your resume.
